# A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-randomised-phase-2-trial-of-nab-paclitaxel-plus-gemcitabine-with-or-without/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Michele Reni,Silvia Zanon,Gianpaolo Balzano,Paolo Passoni,Chiara Pircher,Marta Chiaravalli,Clara Fugazza,Domenica Ceraulo,Roberto Nicoletti,Paolo Giorgio Arcidiacono,Marina Macchini,Umberto Peretti,R. Castoldi,Claudio Doglioni,Massimo Falconi,Stefano Partelli,Luca Gianni |
| Citations | 59 |
| DOI | 10.1016/j.ejca.2018.07.007 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2888094806 |
| PMID | 30149366 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Marina Macchini](https://scholariq.org/researchers/marina-macchini/)

## Paper journal

- [European Journal of Cancer](https://scholariq.org/journals/european-journal-of-cancer/)

## Paper primary topic

- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)

## Paper topics

- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.